Two kinds of record. Five details to keep separate.

This record comparison illustrates information boundaries; it does not select a medicine. Read the disclosure.

Product identity

Approved reference · Brisdelle
Brisdelle identifies a particular paroxetine mesylate oral capsule. Its label describes that finished product.
Advertised offer · CoreAge
CoreAge advertises oral paroxetine. The public description does not identify a complete finished product or manufacturer.

Strength and form

Approved reference · Brisdelle
The approved Brisdelle record concerns a 7.5 mg capsule. Strength and dosage form are part of its identity.
Advertised offer · CoreAge
The advertised CoreAge offer names 10 mg. That number does not establish the same capsule or complete formulation.

Purpose and approval

Approved reference · Brisdelle
Brisdelle’s indication concerns moderate to severe vasomotor symptoms due to menopause. Its approval is product-specific.
Advertised offer · CoreAge
CoreAge describes menopausal use as off-label. The finished medicine and the rationale for the proposed use still need explanation.

Medicine review

Approved reference · Brisdelle
The Brisdelle label includes interaction information, including a concern about tamoxifen. A full medicine review belongs with a professional.
Advertised offer · CoreAge
A provider’s product page does not reconcile the person’s prescriptions, supplements or medical history.

Care and cost

Approved reference · Brisdelle
An approved label is not a clinic package, a prescription quote or a statement of insurance coverage.
Advertised offer · CoreAge
CoreAge advertises a starting monthly offer. The exact supply, follow-up arrangement and total charge need confirmation.

All examples are fixed editorial text. The controls reveal questions; they do not collect medicine details, assess health or produce a recommendation. Choices reset on reload.